ClinConnect ClinConnect Logo
Search / Trial NCT06898827

Distraction Therapy Using Virtual Reality in Cardiac Rehabilitation

Launched by UNIVERSITY OF MALTA · Mar 25, 2025

Trial Information

Current as of April 30, 2025

Enrolling by invitation

Keywords

Cardiac Rehabilitation Virtual Reality Rehabilitation

ClinConnect Summary

Cardiovascular disease is a leading cause of death and morbidity worldwide, with the WHO reporting 17.9 million of all global deaths in 2019 attributed to cardiovascular disease, with 7.4 million deaths attributed to coronary heart disease. In Europe, CVDs are estimated to cause close to 4 million deaths annually, generating a cost of 196 billion Euros/year. Cardiac rehabilitation, an intervention offered to the majority of patients who would have experience any cardiac event, includes several components delivered by a multi-disciplinary team. The components include health education, advice...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients who are suffering from any cardiac condition
  • Patients who have had a cardiac event
  • Patients referred for cardiac rehabilitation.
  • Exclusion Criteria:
  • Patients with Atrial Fibrillation
  • Patients with an implantable cardioverter defibrillator
  • Patients with a pacemaker and
  • Patients who suffer from Vertigo

About University Of Malta

The University of Malta, a premier institution for higher education and research in the Mediterranean region, is committed to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a multidisciplinary approach, the University leverages its extensive expertise in various fields, including medicine, pharmacy, and biomedical sciences, to conduct rigorous and ethically sound research. By fostering collaboration among academic, clinical, and industry partners, the University of Malta aims to translate scientific discoveries into practical applications, ultimately enhancing patient care and contributing to the global body of medical knowledge.

Locations

Imsida, , Malta

Patients applied

0 patients applied

Trial Officials

Dr Anabel Sciriha, PhD

Principal Investigator

University of Malta

Dr Stephen Lungaro-Mifsud, PhD

Principal Investigator

University of Malta

Dr Tonio Agius, PhD

Principal Investigator

University of Malta

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported